(2021) demonstrated that the Wnt/β-catenin signaling pathway inhibitor ICG-001, when used in conjunction with radiotherapy, enhances the DNA damage response and increases the radiosensitivity of HCC by inhibiting the activation of the p53-mediated cGAS-STING pathway (157). The gene discussed is STING1; the disease is hepatocellular carcinoma.